Show
Sort by
-
- Journal Article
- A1
- open access
Week 48 resistance analyses of the once-daily, single-tablet regimen darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in adults living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials
-
Modeling HIV-1 latency in primary T cells using a replication-competent virus
-
Targeting mucosal Fc-Fc receptor interactions as vaccine strategy against mucosal HIV-transmission
-
Transmission network of an HIV type 1 strain with K103N in young Belgian patients from different risk groups
-
- Journal Article
- A1
- open access
HIV type 1 mother-to-child transmission facilitated by distinctive glycosylation sites in the gp120 envelope glycoprotein
-
Greentree white paper: Sexual violence, genitoanal injury, and HIV: priorities for research, policy, and practice
-
Drug resistance mutations in drug-naive HIV type 1 subtype C-infected individuals from rural Malawi
-
An adjuvanted protein HIV vaccine induces polyfunctional CD4 T-cell responses in healthy volunteers similar to those in HIV-infected viral controllers
-
Unreliable Real-Time PCR Analysis of Human Endogenous Retrovirus-W (HERV-W) RNA Expression and DNA Copy Number in Multiple Sclerosis
-
Safety and Availability of Dapivirine (TMC120) Delivered from an Intravaginal Ring
-
Induction of a potent polyfunctional CD4+T cell response by an adjuvanted protein HIV vaccine candidate in seronegative volunteers
-
Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006
-
Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy.
-
Near full-length genome analysis of HIV type 1 CRF02.AG subtype C and CRF02.AG subtype G recombinants.
-
Study of HIV type 1 gag/env variability in The Gambia, using a multiplex DNA polymerase chain reaction.
-
Sequence note - HIV type 1 C2V3 env diversity among Belgian individuals.
-
Genetic variation of HIV type 1: Relevance of interclade variation to vaccine development.
-
GENETIC-VARIABILITY OF HIV TYPE-1 IN KENYA.